2.52
Poseida Therapeutics Inc 주식(PSTX)의 최신 뉴스
The past three years for Poseida Therapeutics (NASDAQ:PSTX) investors has not been profitable - Yahoo Movies UK
Yahoo Movies UK
It is Poised to be a Bull Market for Poseida Therapeutics Inc (PSTX) – Sete News - SETE News
SETE News
These 2 'Strong Buy' Penny Stocks Could Rally to $10 (or More), Say Analysts - Markets Insider
Markets Insider
The past three years for Poseida Therapeutics (NASDAQ:PSTX) investors has not been profitable - Yahoo Movies UK
Yahoo Movies UK
PSTX Stock Update: Poseida Therapeutics Inc’s Banking’s Market Struggles and Potential Opportunities - The InvestChronicle
The InvestChronicle
Cantor Fitzgerald L. P. Purchases New Stake in Poseida Therapeutics, Inc. (NASDAQ:PSTX) - Defense World
Defense World
Reviewing Poseida Therapeutics (NASDAQ:PSTX) and Biogen (NASDAQ:BIIB) - Defense World
Defense World
Poseida Therapeutics Announces Virtual 2024 Annual Meeting of Stockholders - Lelezard
Lelezard
Poseida Therapeutics Announces Virtual 2024 Annual Meeting of Stockholders - The Malaysian Reserve
The Malaysian Reserve
Poseida Therapeutics Announces Virtual 2024 Annual Meeting of Stockholders - Marketscreener.com
Marketscreener.com
Poseida Therapeutics Announces Virtual 2024 Annual Meeting of Stockholders - Yahoo Finance
Yahoo Finance
Poseida Therapeutics Announces Virtual 2024 Annual Meeting of Stockholders - Yahoo Finance
Yahoo Finance
Poseida Therapeutics, Inc. (NASDAQ:PSTX) Short Interest Update - MarketBeat
MarketBeat
Poseida Therapeutics, Inc. (NASDAQ:PSTX) Short Interest Update - Defense World
Defense World
Poseida Therapeutics, Inc. (NASDAQ:PSTX) Short Interest Update - MarketBeat
MarketBeat
Quarterly Snapshot: Quick and Current Ratios for Poseida Therapeutics Inc (PSTX) – DWinneX - The Dwinnex
The Dwinnex
Poseida Therapeutics Partners With Astellas: Worth Watching For Now (NASDAQ:PSTX) - Seeking Alpha
Seeking Alpha
10459 Shares in Poseida Therapeutics, Inc. (NASDAQ:PSTX) Acquired by Dynamic Technology Lab Private Ltd - Defense World
Defense World
Poseida Therapeutics Partners With Astellas: Worth Watching For Now (NASDAQ:PSTX) - Seeking Alpha
Seeking Alpha
What is Poseida Therapeutics Inc (PSTX) Stock Return on Shareholders' Capital? – Sete News - SETE News
SETE News
Poseida Therapeutics, Inc. to Post Q2 2024 Earnings of ($0.43) Per Share, HC Wainwright Forecasts (NASDAQ:PSTX) - Defense World
Defense World
Poseida Therapeutics, Inc. to Post Q2 2024 Earnings of ($0.43) Per Share, HC Wainwright Forecasts (NASDAQ:PSTX) - Defense World
Defense World
Poseida Therapeutics, Inc. Forecasted to Post Q2 2024 Earnings of ($0.43) Per Share (NASDAQ:PSTX) - MarketBeat
MarketBeat
Poseida Therapeutics, Inc. (NASDAQ:PSTX) Expected to Post Q3 2025 Earnings of ($0.49) Per Share - Defense World
Defense World
Poseida Therapeutics, Inc. (NASDAQ:PSTX) Expected to Post Q3 2025 Earnings of ($0.49) Per Share - Defense World
Defense World
Q3 2025 Earnings Estimate for Poseida Therapeutics, Inc. (NASDAQ:PSTX) Issued By HC Wainwright - MarketBeat
MarketBeat
Poseida Therapeutics (NASDAQ:PSTX) Receives Buy Rating from HC Wainwright - Defense World
Defense World
Q3 2025 Earnings Estimate for Poseida Therapeutics, Inc. (NASDAQ:PSTX) Issued By HC Wainwright - MarketBeat
MarketBeat
Poseida Therapeutics (NASDAQ:PSTX) Earns Buy Rating from HC Wainwright - MarketBeat
MarketBeat
Company’s Banking Stock: Dissecting a -11.08% Quarterly Revenue Decline Amid Growth - The InvestChronicle
The InvestChronicle
Financial Metrics Unveiled: Poseida Therapeutics Inc (PSTX)'s Key Ratios in the Spotlight – DWinneX - The Dwinnex
The Dwinnex
Ready to Jump After Recent Trade: Poseida Therapeutics Inc (PSTX) – Sete News - SETE News
SETE News
Biotech Soars on Research Collaboration And License Agreement Release - The Globe and Mail
The Globe and Mail
Do investors need to be concerned about Poseida Therapeutics Inc (PSTX)? – US Post News - US Post News
US Post News
Poseida Therapeutics (NASDAQ:PSTX) Has Debt But No Earnings; Should You Worry? - Simply Wall St
Simply Wall St
Poseida Therapeutics (NASDAQ:PSTX) Has Debt But No Earnings; Should You Worry? - Simply Wall St
Simply Wall St
New York State Common Retirement Fund Sells 17966 Shares of Poseida Therapeutics, Inc. (NASDAQ:PSTX) - Defense World
Defense World
New York State Common Retirement Fund Sells 17966 Shares of Poseida Therapeutics, Inc. (NASDAQ:PSTX) - Defense World
Defense World
Biotech Soars on Research Collaboration And License Agreement Release - The Globe and Mail
The Globe and Mail
William Blair Weighs in on Poseida Therapeutics, Inc.'s Q2 2024 Earnings (NASDAQ:PSTX) - Defense World
Defense World
Q2 2024 EPS Estimates for Poseida Therapeutics, Inc. (NASDAQ:PSTX) Cut by Analyst - MarketBeat
MarketBeat
Poseida Therapeutics Inc (PSTX) Stock: Uncovering 52-Week Market Trends - The InvestChronicle
The InvestChronicle
Poseida Therapeutics Inc (PSTX) Stock: Uncovering 52-Week Market Trends - The InvestChronicle
The InvestChronicle
PSTX Stock Earnings: Poseida Therapeutics Beats EPS, Beats Revenue for Q1 2024 - MSN
MSN
Poseida Therapeutics Provides Updates and Financial Results for the First Quarter of 2024 - PR Newswire
PR Newswire
Poseida Therapeutics Provides Updates and Financial Results for the First Quarter of 2024 - PR Newswire
PR Newswire
Akoya Biosciences (AKYA) Reports Q1 Loss, Lags Revenue Estimates
Zacks Investment Research
Institutional investors may adopt severe steps after Poseida Therapeutics, Inc.'s (NASDAQ:PSTX) latest 13% drop adds ... - Yahoo Lifestyle UK
Yahoo Lifestyle UK
One to Watch Companies - USA, SY-2101, Poseida Therapeutics - The Pharma Letter
The Pharma Letter
Poseida Highlights Strong Progress on Its Genetic Medicine Programs at the American Society for Gene and Cell ... - PR Newswire
PR Newswire
자본화:
|
볼륨(24시간):